{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T01:27:54Z","timestamp":1722907674354},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/jjco\/hyx169","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:11:41Z","timestamp":1509581501000},"page":"295-296","source":"Crossref","is-referenced-by-count":0,"title":["Prevention of IVR: a need for investigation"],"prefix":"10.1093","volume":"48","author":[{"given":"Idir","family":"Ouzaid","sequence":"first","affiliation":[{"name":"Department of Urology, Bichat Hospital, APHP, Paris Diderot University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evanguelos","family":"Xylinas","sequence":"additional","affiliation":[{"name":"Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Young Academic Urologists of the European Association of Urology Urothelial Carcinoma Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"key\n\t\t\t\t20180328182238_hyx169C1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1464-410X.2008.07438.x","article-title":"Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract","volume":"101","author":"Novara","year":"2008","journal-title":"BJU Int"},{"key":"key\n\t\t\t\t20180328182238_hyx169C2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","article-title":"Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"key":"key\n\t\t\t\t20180328182238_hyx169C3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1442-2042.2001.00286.x","article-title":"Kyushu University Urological Oncology G: prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study","volume":"8","author":"Sakamoto","year":"2001","journal-title":"Int J Urol"},{"key":"key\n\t\t\t\t20180328182238_hyx169C4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","article-title":"British Association of Urological Surgeons Section of O: prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)","volume":"60","author":"O\u2019Brien","year":"2011","journal-title":"Eur Urol"},{"key":"key\n\t\t\t\t20180328182238_hyx169C5","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","article-title":"Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial","volume":"31","author":"Ito","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180328182238_hyx169C6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/jjco\/hyx085","article-title":"Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial","volume":"47","author":"Yamashita","year":"2017","journal-title":"Jpn J Clin Oncol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/48\/3\/295\/24238911\/hyx169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T03:51:18Z","timestamp":1522295478000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/48\/3\/295\/4797157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":6,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,1,10]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyx169","relation":{},"ISSN":["0368-2811","1465-3621"],"issn-type":[{"type":"print","value":"0368-2811"},{"type":"electronic","value":"1465-3621"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2018,1,10]]}}}